|
11/06/2008--
Columbia Laboratories to Report Third
Quarter 2008 Financial Results
10/30/2008--
Columbia Laboratories To Discuss Third
Quarter Financial Results On November 6, 2008 Conference Call
10/23/2008--
Columbia Laboratories Enters
Collaborative Agreement with the National institutes of Health (NIH)
10/22/2008--
Columbia Laboratories to Present at the
Oppenheimer & Co. 19th Annual Healthcare Conference on November
3,2008
10/08/2008--
Columbia Laboratories Reiterates 2008
Year-End Revenue Guidance
09/29/2008--
Columbia Laboratories Reports Results
from Phase II Clinical Trial of Vaginally-administered Lidocaine for
Dysmenorrhea
09/16/2008--
Columbia Laboratories to Present at
The UBS 2008 Global Life Sciences Conference on September 22, 2008
09/08/2008--
Columbia Laboratories to Release Top
Line Results of Phase II Lidocaine Study in Late September
08/26/2008--
Columbia Laboratories Closes
Registered Direct Common Stock Offering
08/22/2008--
Columbia Laboratories Announces
Registered Direct Common Stock Offering
08/07/2008--
Columbia Laboratories to Report Second
Quarter Financial Results
07/30/2008--
Columbia Laboratories to Report Second
Quarter Financial Results Conference Call
06/24/2008--
Columbia Laboratories set to join
Russell 3000® Index
05/08/2008--
Columbia Laboratories to Report First
Quarter Financial Results
05/06/2008--
Columbia Laboratories to Discuss First
Quarter Financial Results on May 8, 2008 Conference Call
04/14/2008 --
Vaginal Progesterone is Equally
Effective in Achieving Pregnancy Outcomes as Injectable Progesterone in Donor Egg Cycles
04/08/2008--
Columbia Laboratories Demonstrates
Commitment to Reproductive Health as Sapphire Sponsor of Pacific Coast
Reproductive Society Annual Meeting
03/18/2008--
Columbia Laboratories to Restate
Earnings Due to Adjustments For Interest Expense
03/11/2008--
Columbia Laboratories Reports Fourth
Quarter and Year-End 2007 Financial Results
03/05/2008--
Columbia Laboratories to Discuss
Fourth Quarter and Year End 2007 Financial Results on March 11, 2008 Conference
Call
02/25/2008
Columbia Laboratories to Present at
the Jesup and Lamont 2008 Emerging Growth Stock Conference in Orlando, FL on
February 28, 2008
02/13/20008--
New Website Explaining Role of
Progesterone Support in Pregnancy And Fertility Launched By Columbia
Laboratories, Inc.
02/11/2008--
Columbia Laboratories to Present at
the ROTH Capital Partners 20th Annual OC Growth Stock Conference in Dana Point,
California on February 20, 2008
02/05/2008--
Columbia Laboratories Receives IRB
Approval to Begin Enrolling Patients in Phase III Study of PROCHIEVE® 8%
(progesterone gel) to Reduce Risk of Preterm Birth in Short Cervix Population
01/31/2008--
Data from Columbia Laboratories’
Study for the Prevention of Preterm Birth to be Presented at the Society for
Maternal-Fetal Medicine (SMFM) 2008 Annual Meeting
| 
